BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 33384007)

  • 1. Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder.
    Goodman WK; Storch EA; Sheth SA
    Am J Psychiatry; 2021 Jan; 178(1):17-29. PubMed ID: 33384007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obsessive-compulsive disorder.
    Goodman WK; Grice DE; Lapidus KA; Coffey BJ
    Psychiatr Clin North Am; 2014 Sep; 37(3):257-67. PubMed ID: 25150561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced functional connectivity within the limbic cortico-striato-thalamo-cortical loop in unmedicated adults with obsessive-compulsive disorder.
    Posner J; Marsh R; Maia TV; Peterson BS; Gruber A; Simpson HB
    Hum Brain Mapp; 2014 Jun; 35(6):2852-60. PubMed ID: 24123377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The right thalamic glutamate level correlates with functional connectivity with right dorsal anterior cingulate cortex/middle occipital gyrus in unmedicated obsessive-compulsive disorder: A combined fMRI and
    Chen Y; Meng Z; Zhang Z; Zhu Y; Gao R; Cao X; Tan L; Wang Z; Zhang H; Li Y; Fan Q
    Aust N Z J Psychiatry; 2019 Mar; 53(3):207-218. PubMed ID: 30354192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the dorsal anterior cingulate cortex in obsessive-compulsive disorder: converging evidence from cognitive neuroscience and psychiatric neurosurgery.
    McGovern RA; Sheth SA
    J Neurosurg; 2017 Jan; 126(1):132-147. PubMed ID: 27035167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroscientifically Informed Formulation and Treatment Planning for Patients With Obsessive-Compulsive Disorder: A Review.
    Dougherty DD; Brennan BP; Stewart SE; Wilhelm S; Widge AS; Rauch SL
    JAMA Psychiatry; 2018 Oct; 75(10):1081-1087. PubMed ID: 30140845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The medial forebrain bundle as a target for deep brain stimulation for obsessive-compulsive disorder.
    Coenen VA; Schlaepfer TE; Goll P; Reinacher PC; Voderholzer U; Tebartz van Elst L; Urbach H; Freyer T
    CNS Spectr; 2017 Jun; 22(3):282-289. PubMed ID: 27268576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limbic cortico-striato-thalamo-cortical functional connectivity in drug-naïve patients of obsessive-compulsive disorder.
    Zhao Q; Xu T; Wang Y; Chen D; Liu Q; Yang Z; Wang Z
    Psychol Med; 2021 Jan; 51(1):70-82. PubMed ID: 31640827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S; Harvey BH
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Psychopharmacology of Obsessive-Compulsive Disorder: A Preclinical Roadmap.
    Szechtman H; Harvey BH; Woody EZ; Hoffman KL
    Pharmacol Rev; 2020 Jan; 72(1):80-151. PubMed ID: 31826934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities within and beyond the cortico-striato-thalamo-cortical circuitry in medication-free patients with OCD revealed by the fractional amplitude of low-frequency fluctuations and resting-state functional connectivity.
    Gao J; Zhou Y; Yang X; Luo J; Meng F; Zheng D; Li Z
    Neurosci Lett; 2019 Nov; 712():134449. PubMed ID: 31470044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.
    Pittenger C; Krystal JH; Coric V
    NeuroRx; 2006 Jan; 3(1):69-81. PubMed ID: 16490414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain-behavior relationships in obsessive-compulsive disorder.
    Saxena S; Bota RG; Brody AL
    Semin Clin Neuropsychiatry; 2001 Apr; 6(2):82-101. PubMed ID: 11296309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary Observations of Resting-State Magnetoencephalography in Nonmedicated Children with Obsessive-Compulsive Disorder.
    Tan V; Dockstader C; Moxon-Emre I; Mendlowitz S; Schacter R; Colasanto M; Voineskos AN; Akingbade A; Nishat E; Mabbott DJ; Arnold PD; Ameis SH
    J Child Adolesc Psychopharmacol; 2022 Dec; 32(10):522-532. PubMed ID: 36548364
    [No Abstract]   [Full Text] [Related]  

  • 15. Learning From Animal Models of Obsessive-Compulsive Disorder.
    Monteiro P; Feng G
    Biol Psychiatry; 2016 Jan; 79(1):7-16. PubMed ID: 26037910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Directions in the Use of Brain Stimulation Interventions in Patients with Obsessive-Compulsive Disorder.
    Dell'Osso B; Cremaschi L; Oldani L; Altamura AC
    Curr Med Chem; 2018; 25(41):5712-5721. PubMed ID: 28474552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reductions in Cortico-Striatal Hyperconnectivity Accompany Successful Treatment of Obsessive-Compulsive Disorder with Dorsomedial Prefrontal rTMS.
    Dunlop K; Woodside B; Olmsted M; Colton P; Giacobbe P; Downar J
    Neuropsychopharmacology; 2016 Apr; 41(5):1395-403. PubMed ID: 26440813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Preferences and Acceptability of Evidence-Based and Novel Treatments for Obsessive-Compulsive Disorder.
    Patel SR; Galfavy H; Kimeldorf MB; Dixon LB; Simpson HB
    Psychiatr Serv; 2017 Mar; 68(3):250-257. PubMed ID: 27745541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition and treatment of obsessive-compulsive disorder.
    Goodman WK; Lydiard RB
    J Clin Psychiatry; 2007 Dec; 68(12):e30. PubMed ID: 18162010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromodulation for obsessive-compulsive disorder.
    Lapidus KA; Stern ER; Berlin HA; Goodman WK
    Neurotherapeutics; 2014 Jul; 11(3):485-95. PubMed ID: 24981434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.